common glp 1 agonists Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia common glp 1 agonists GLP-1
Description
doi: 10.3390/nu11071664 50 WangYHeWWeiWMeiXYangMWangY
Clinical trials showed average weight loss of 20-25% of body weight with tirzepatide at the highest doses, compared to 15-17% with semaglutide
In summary, GLP-2 has a significant inhibitory effect on bone resorption with minimal impact on bone formation, resulting in increased BMD
Metab Brain Dis (2017) 32:173545
Lu Z, et al
Retatrutide 0.5, 1.5, and 3 mg were administered for 12 weeks
